Microplastics in preschoolers: Investigating exposure, diet, and gut microbiota

SAN DIEGO — A time-limited, targeted combination significantly improved survival compared with chemoimmunotherapy in fit chronic lymphocytic leukemia (CLL) patients who met criteria for starting

Roche pulled its mar­ket­ing au­tho­riza­tion ap­pli­ca­tion with the Eu­ro­pean Med­i­cines Agency (EMA) ear­li­er this month to ex­pand the la­bel for its can­cer med­i­cine Gazy­varo, be­cause